Recalcitrant transient abnormal myelopoiesis in neonatal Down syndrome

Pediatr Blood Cancer. 2022 Oct;69(10):e29662. doi: 10.1002/pbc.29662. Epub 2022 Mar 16.

Authors

Sophie Timmis¹, Angus Hodder¹, Niteesh Bharadwaj¹, Sarah Inglott², Jane Chalker³, Danny Cheng¹, Sneha Tandon⁴, Jack Bartram¹

Affiliations

¹ Department of Haematology, Great Ormond Street Hospital for Children, London, UK.
² Flow Cytometry SIHMDS-Haematology, Great Ormond Street Hospital for Children, London, UK.
³ SIHMDS-Acquired Genomics, NHS North Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children, London, UK.
⁴ Department of Paediatric Haematology, Royal London Hospital, London, UK.

PMID: 35293681
DOI: 10.1002/pbc.29662

No abstract available

Publication types

Letter

MeSH terms

Down Syndrome* / complications
Down Syndrome* / genetics
Humans
Infant, Newborn
Leukemoid Reaction* / genetics
Myelopoiesis

Supplementary concepts

Myeloproliferative Syndrome, Transient